Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hysteroscopy | 21 | 2023 | 102 | 5.070 |
Why?
|
Gynatresia | 9 | 2023 | 15 | 4.180 |
Why?
|
Uterine Diseases | 13 | 2023 | 135 | 3.660 |
Why?
|
Endometrium | 19 | 2023 | 424 | 1.980 |
Why?
|
Leiomyoma | 14 | 2021 | 730 | 1.860 |
Why?
|
Gynecologic Surgical Procedures | 7 | 2018 | 336 | 1.710 |
Why?
|
Infertility, Female | 14 | 2022 | 787 | 1.660 |
Why?
|
Uterine Neoplasms | 15 | 2023 | 1513 | 1.540 |
Why?
|
Laparoscopy | 22 | 2022 | 2151 | 1.520 |
Why?
|
Endometriosis | 19 | 2022 | 839 | 1.380 |
Why?
|
Uterus | 10 | 2021 | 711 | 1.360 |
Why?
|
Hysteroscopes | 6 | 2021 | 8 | 1.300 |
Why?
|
Tissue Adhesions | 11 | 2023 | 235 | 1.260 |
Why?
|
Hysterectomy | 15 | 2023 | 927 | 1.160 |
Why?
|
Pregnancy, Tubal | 1 | 2023 | 16 | 0.900 |
Why?
|
Fertilization in Vitro | 13 | 2021 | 1284 | 0.900 |
Why?
|
Endometrial Ablation Techniques | 3 | 2015 | 11 | 0.800 |
Why?
|
Mesenchymoma | 1 | 2017 | 47 | 0.610 |
Why?
|
Primary Ovarian Insufficiency | 3 | 2013 | 115 | 0.590 |
Why?
|
Specimen Handling | 2 | 2019 | 694 | 0.590 |
Why?
|
Neoplasm Seeding | 1 | 2015 | 87 | 0.530 |
Why?
|
Metrorrhagia | 1 | 2015 | 18 | 0.530 |
Why?
|
Complement C3 | 6 | 1999 | 461 | 0.530 |
Why?
|
Patient Preference | 2 | 2013 | 890 | 0.520 |
Why?
|
Robotics | 2 | 2020 | 899 | 0.490 |
Why?
|
Intrauterine Device Migration | 1 | 2014 | 6 | 0.490 |
Why?
|
Pregnancy | 26 | 2023 | 29144 | 0.480 |
Why?
|
Surgery Department, Hospital | 1 | 2015 | 175 | 0.450 |
Why?
|
Intrauterine Devices | 1 | 2014 | 122 | 0.420 |
Why?
|
Uterine Artery | 1 | 2012 | 36 | 0.410 |
Why?
|
Female | 104 | 2023 | 380194 | 0.410 |
Why?
|
Ascitic Fluid | 4 | 2020 | 192 | 0.410 |
Why?
|
Fertility | 5 | 2023 | 781 | 0.400 |
Why?
|
Leiomyosarcoma | 1 | 2015 | 477 | 0.400 |
Why?
|
Pregnancy Rate | 5 | 2022 | 643 | 0.380 |
Why?
|
Electrosurgery | 4 | 2009 | 58 | 0.360 |
Why?
|
Intraoperative Complications | 3 | 2009 | 1198 | 0.360 |
Why?
|
Myometrium | 2 | 2020 | 181 | 0.340 |
Why?
|
Electrocoagulation | 5 | 2009 | 158 | 0.340 |
Why?
|
Menorrhagia | 3 | 2020 | 63 | 0.330 |
Why?
|
Device Removal | 1 | 2014 | 656 | 0.330 |
Why?
|
Publishing | 1 | 2016 | 833 | 0.320 |
Why?
|
Premature Birth | 1 | 2020 | 1721 | 0.320 |
Why?
|
alpha-Macroglobulins | 3 | 1997 | 64 | 0.320 |
Why?
|
Abdominal Pain | 1 | 2014 | 1063 | 0.300 |
Why?
|
Menstrual Cycle | 4 | 2020 | 551 | 0.280 |
Why?
|
Humans | 102 | 2023 | 744343 | 0.280 |
Why?
|
Sarcoma | 1 | 2017 | 1897 | 0.270 |
Why?
|
Surgical Instruments | 4 | 2002 | 395 | 0.270 |
Why?
|
Peritoneal Diseases | 2 | 2020 | 75 | 0.260 |
Why?
|
Ultrasonography | 6 | 2020 | 5985 | 0.250 |
Why?
|
Embolism, Air | 2 | 2002 | 111 | 0.240 |
Why?
|
Embolization, Therapeutic | 2 | 2012 | 1392 | 0.230 |
Why?
|
Pregnancy Outcome | 5 | 2020 | 2795 | 0.230 |
Why?
|
Myoma | 1 | 2023 | 10 | 0.230 |
Why?
|
Extracellular Matrix | 2 | 2023 | 1741 | 0.220 |
Why?
|
Cytokines | 5 | 2022 | 7322 | 0.210 |
Why?
|
Embryo Transfer | 3 | 2020 | 510 | 0.210 |
Why?
|
Genital Diseases, Female | 3 | 2013 | 197 | 0.210 |
Why?
|
Infertility | 3 | 2019 | 655 | 0.200 |
Why?
|
Direct Service Costs | 1 | 2001 | 62 | 0.200 |
Why?
|
Adult | 50 | 2023 | 214055 | 0.200 |
Why?
|
Reproductive Techniques, Assisted | 2 | 2020 | 482 | 0.200 |
Why?
|
Ovulation Induction | 3 | 2013 | 274 | 0.200 |
Why?
|
Placenta Previa | 1 | 2022 | 117 | 0.190 |
Why?
|
Laparoscopes | 2 | 1999 | 41 | 0.190 |
Why?
|
Delivery of Health Care | 2 | 2018 | 5319 | 0.190 |
Why?
|
Dyspareunia | 1 | 2020 | 50 | 0.190 |
Why?
|
Mandatory Reporting | 1 | 2001 | 121 | 0.190 |
Why?
|
Fallopian Tubes | 2 | 2009 | 182 | 0.180 |
Why?
|
Research Design | 1 | 2016 | 5987 | 0.180 |
Why?
|
Dysmenorrhea | 1 | 2020 | 86 | 0.180 |
Why?
|
Uterine Hemorrhage | 2 | 2002 | 255 | 0.180 |
Why?
|
Endoscopy | 2 | 2020 | 1785 | 0.180 |
Why?
|
Quality of Life | 4 | 2018 | 12804 | 0.170 |
Why?
|
Birth Rate | 1 | 2020 | 170 | 0.170 |
Why?
|
Placenta Accreta | 1 | 2022 | 225 | 0.170 |
Why?
|
Biopsy, Needle | 3 | 2019 | 1641 | 0.160 |
Why?
|
Dilatation and Curettage | 1 | 2018 | 56 | 0.160 |
Why?
|
Povidone | 1 | 1998 | 33 | 0.160 |
Why?
|
Pelvis | 2 | 2020 | 730 | 0.160 |
Why?
|
Centrifugation, Density Gradient | 1 | 1998 | 313 | 0.160 |
Why?
|
Brenner Tumor | 1 | 1997 | 8 | 0.160 |
Why?
|
Gonadal Dysgenesis, 46,XY | 1 | 1997 | 11 | 0.160 |
Why?
|
Postoperative Care | 2 | 2018 | 1486 | 0.150 |
Why?
|
Urinary Retention | 1 | 2018 | 111 | 0.150 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2002 | 454 | 0.150 |
Why?
|
Postoperative Complications | 5 | 2018 | 15295 | 0.150 |
Why?
|
Inhibins | 4 | 2000 | 211 | 0.150 |
Why?
|
Silicon Dioxide | 1 | 1998 | 213 | 0.150 |
Why?
|
Matrix Metalloproteinases | 1 | 2019 | 391 | 0.150 |
Why?
|
Hematometra | 2 | 2011 | 5 | 0.140 |
Why?
|
Retrospective Studies | 16 | 2022 | 77449 | 0.140 |
Why?
|
Spermatozoa | 2 | 1998 | 625 | 0.140 |
Why?
|
Massachusetts | 3 | 2020 | 8663 | 0.140 |
Why?
|
Inappropriate Prescribing | 1 | 2018 | 202 | 0.140 |
Why?
|
Colon, Sigmoid | 1 | 1996 | 120 | 0.140 |
Why?
|
Polyploidy | 1 | 1996 | 114 | 0.140 |
Why?
|
Zygote | 1 | 1996 | 116 | 0.140 |
Why?
|
Complementary Therapies | 1 | 2020 | 486 | 0.130 |
Why?
|
Immunoassay | 1 | 2019 | 752 | 0.130 |
Why?
|
Abortion, Spontaneous | 2 | 2020 | 544 | 0.130 |
Why?
|
Ultrasonics | 1 | 1996 | 212 | 0.130 |
Why?
|
Iatrogenic Disease | 1 | 2018 | 547 | 0.130 |
Why?
|
Morbidity | 1 | 2020 | 1769 | 0.130 |
Why?
|
Perception | 1 | 2021 | 1198 | 0.120 |
Why?
|
Suture Techniques | 2 | 2010 | 798 | 0.120 |
Why?
|
Mice, SCID | 1 | 1999 | 2716 | 0.120 |
Why?
|
Cesarean Section | 1 | 2023 | 1365 | 0.120 |
Why?
|
Prospective Studies | 19 | 2022 | 53288 | 0.120 |
Why?
|
Hydatidiform Mole | 1 | 1996 | 279 | 0.120 |
Why?
|
Ovarian Neoplasms | 2 | 2023 | 4838 | 0.120 |
Why?
|
Gene Expression | 2 | 1997 | 7799 | 0.110 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 944 | 0.110 |
Why?
|
Receptors, LDL | 1 | 1995 | 475 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2014 | 286 | 0.110 |
Why?
|
Oocytes | 6 | 2002 | 1187 | 0.110 |
Why?
|
Endosonography | 1 | 1997 | 610 | 0.110 |
Why?
|
Coloring Agents | 1 | 2015 | 566 | 0.110 |
Why?
|
Cervix Uteri | 2 | 1999 | 590 | 0.110 |
Why?
|
Metalloproteases | 1 | 2012 | 62 | 0.110 |
Why?
|
Prognosis | 5 | 2020 | 29063 | 0.110 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1738 | 0.110 |
Why?
|
Catheter Ablation | 2 | 2017 | 2758 | 0.110 |
Why?
|
Hormones | 3 | 2023 | 889 | 0.100 |
Why?
|
Middle Aged | 24 | 2019 | 213383 | 0.100 |
Why?
|
Pain, Postoperative | 2 | 2020 | 1643 | 0.100 |
Why?
|
Sensitivity and Specificity | 4 | 2019 | 14722 | 0.100 |
Why?
|
Enzyme Assays | 1 | 2012 | 111 | 0.100 |
Why?
|
Fallopian Tube Diseases | 1 | 1992 | 62 | 0.100 |
Why?
|
Hematocolpos | 1 | 2011 | 6 | 0.100 |
Why?
|
ADAM Proteins | 1 | 2013 | 243 | 0.100 |
Why?
|
Apoptosis | 2 | 1998 | 9727 | 0.100 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2007 | 397 | 0.100 |
Why?
|
Stromal Cells | 1 | 2017 | 1355 | 0.100 |
Why?
|
Estrogens, Conjugated (USP) | 2 | 2012 | 275 | 0.100 |
Why?
|
Macrophage Activation | 1 | 2014 | 558 | 0.090 |
Why?
|
In Situ Hybridization | 4 | 1999 | 1950 | 0.090 |
Why?
|
Precancerous Conditions | 1 | 2017 | 975 | 0.090 |
Why?
|
Treatment Outcome | 14 | 2021 | 63114 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 1997 | 1434 | 0.090 |
Why?
|
Mullerian Ducts | 1 | 2011 | 198 | 0.090 |
Why?
|
Infant, Newborn | 2 | 2020 | 25625 | 0.090 |
Why?
|
Specialization | 1 | 2015 | 777 | 0.090 |
Why?
|
Prevalence | 4 | 2020 | 15226 | 0.090 |
Why?
|
Ovarian Hyperstimulation Syndrome | 3 | 1999 | 53 | 0.090 |
Why?
|
Thermography | 1 | 2009 | 67 | 0.090 |
Why?
|
Receptors, Immunologic | 1 | 1995 | 1423 | 0.090 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2013 | 584 | 0.090 |
Why?
|
Immunohistochemistry | 6 | 1999 | 11366 | 0.080 |
Why?
|
Granulosa Cells | 2 | 2000 | 120 | 0.080 |
Why?
|
Estradiol | 4 | 2000 | 2020 | 0.080 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1405 | 0.080 |
Why?
|
Membrane Proteins | 2 | 2013 | 7880 | 0.080 |
Why?
|
Health Resources | 2 | 2007 | 911 | 0.080 |
Why?
|
Polyesters | 1 | 2010 | 363 | 0.080 |
Why?
|
Punctures | 1 | 2009 | 374 | 0.080 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12959 | 0.080 |
Why?
|
United States Food and Drug Administration | 1 | 2015 | 1584 | 0.080 |
Why?
|
Ovarian Follicle | 2 | 2001 | 247 | 0.080 |
Why?
|
Abdominal Wall | 1 | 2009 | 157 | 0.080 |
Why?
|
Leiomyomatosis | 1 | 2007 | 70 | 0.070 |
Why?
|
Follicular Fluid | 2 | 2000 | 87 | 0.070 |
Why?
|
Amenorrhea | 1 | 2011 | 485 | 0.070 |
Why?
|
Incidence | 3 | 2023 | 20947 | 0.070 |
Why?
|
Precipitin Tests | 3 | 1995 | 829 | 0.070 |
Why?
|
Ureter | 1 | 2009 | 375 | 0.070 |
Why?
|
Coculture Techniques | 2 | 2023 | 1341 | 0.070 |
Why?
|
Laser Therapy | 2 | 1994 | 1072 | 0.070 |
Why?
|
Catheterization | 1 | 1992 | 1470 | 0.070 |
Why?
|
Arteries | 2 | 2008 | 1119 | 0.070 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2012 | 828 | 0.070 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1526 | 0.070 |
Why?
|
Growth Substances | 2 | 1998 | 784 | 0.070 |
Why?
|
Vagina | 1 | 2011 | 825 | 0.070 |
Why?
|
Young Adult | 7 | 2022 | 56430 | 0.070 |
Why?
|
Skin Transplantation | 1 | 2011 | 1074 | 0.070 |
Why?
|
Hysterosalpingography | 2 | 2017 | 30 | 0.070 |
Why?
|
Disposable Equipment | 2 | 1997 | 43 | 0.060 |
Why?
|
Risk | 1 | 2017 | 9687 | 0.060 |
Why?
|
Cicatrix | 1 | 2011 | 764 | 0.060 |
Why?
|
Gene Regulatory Networks | 1 | 2014 | 1708 | 0.060 |
Why?
|
Inflammation | 3 | 2020 | 10638 | 0.060 |
Why?
|
Pilot Projects | 5 | 2020 | 8324 | 0.060 |
Why?
|
Renal Artery | 1 | 2007 | 398 | 0.060 |
Why?
|
Epithelial Cells | 1 | 2017 | 3690 | 0.060 |
Why?
|
Hot Temperature | 2 | 2009 | 1354 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 1997 | 4554 | 0.060 |
Why?
|
Risk Factors | 7 | 2021 | 72290 | 0.060 |
Why?
|
Adolescent | 6 | 2020 | 85781 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 1995 | 3768 | 0.060 |
Why?
|
Sleep | 1 | 2020 | 4623 | 0.060 |
Why?
|
Lasers | 2 | 2002 | 952 | 0.060 |
Why?
|
Disease Progression | 1 | 2020 | 13284 | 0.060 |
Why?
|
Veins | 1 | 2008 | 770 | 0.060 |
Why?
|
Blood Loss, Surgical | 3 | 2014 | 662 | 0.060 |
Why?
|
Culture Techniques | 2 | 1997 | 554 | 0.060 |
Why?
|
Blood Vessels | 1 | 2009 | 1125 | 0.060 |
Why?
|
Follicle Stimulating Hormone | 3 | 2001 | 744 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2017 | 19905 | 0.060 |
Why?
|
Intestine, Small | 1 | 2009 | 1241 | 0.060 |
Why?
|
Urinary Bladder | 1 | 2009 | 1172 | 0.060 |
Why?
|
Cohort Studies | 3 | 2022 | 40561 | 0.050 |
Why?
|
Tumor Burden | 2 | 2021 | 1915 | 0.050 |
Why?
|
Sperm Count | 1 | 2003 | 216 | 0.050 |
Why?
|
Germany | 2 | 2015 | 862 | 0.050 |
Why?
|
Cell Movement | 2 | 2013 | 5217 | 0.050 |
Why?
|
beta-Thromboglobulin | 1 | 2002 | 24 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3674 | 0.050 |
Why?
|
Sperm Motility | 1 | 2003 | 253 | 0.050 |
Why?
|
Surgical Flaps | 1 | 2011 | 1640 | 0.050 |
Why?
|
Ovariectomy | 2 | 2023 | 661 | 0.050 |
Why?
|
RNA, Messenger | 5 | 2000 | 13033 | 0.050 |
Why?
|
Glycoproteins | 3 | 2000 | 2263 | 0.050 |
Why?
|
Recurrence | 3 | 2020 | 8340 | 0.050 |
Why?
|
Chemotactic Factors | 1 | 2002 | 199 | 0.050 |
Why?
|
Estrogens | 2 | 2023 | 1566 | 0.050 |
Why?
|
Health Care Costs | 2 | 2007 | 3209 | 0.050 |
Why?
|
Receptors, Growth Factor | 2 | 2000 | 334 | 0.050 |
Why?
|
Semen | 1 | 2003 | 316 | 0.050 |
Why?
|
Sperm Injections, Intracytoplasmic | 1 | 2002 | 160 | 0.050 |
Why?
|
Blotting, Western | 3 | 1997 | 5179 | 0.050 |
Why?
|
Prostatic Secretory Proteins | 1 | 2000 | 25 | 0.050 |
Why?
|
Gynecology | 2 | 1999 | 513 | 0.050 |
Why?
|
Models, Animal | 1 | 2007 | 2171 | 0.050 |
Why?
|
Patient Care | 1 | 2006 | 640 | 0.050 |
Why?
|
Aged | 7 | 2023 | 163280 | 0.050 |
Why?
|
Workload | 1 | 2006 | 850 | 0.050 |
Why?
|
Pelvic Bones | 1 | 2002 | 265 | 0.050 |
Why?
|
Infertility, Male | 1 | 2003 | 409 | 0.050 |
Why?
|
Peptides | 3 | 2023 | 4409 | 0.040 |
Why?
|
Transplantation, Heterotopic | 1 | 1999 | 175 | 0.040 |
Why?
|
Uterine Perforation | 1 | 1999 | 6 | 0.040 |
Why?
|
Pain Measurement | 2 | 2020 | 3420 | 0.040 |
Why?
|
Solutions | 1 | 2000 | 426 | 0.040 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 1994 | 1801 | 0.040 |
Why?
|
Wireless Technology | 1 | 2020 | 100 | 0.040 |
Why?
|
Operating Rooms | 1 | 2006 | 817 | 0.040 |
Why?
|
Endometritis | 1 | 1999 | 48 | 0.040 |
Why?
|
Treatment Failure | 2 | 2020 | 2618 | 0.040 |
Why?
|
Length of Stay | 3 | 2014 | 6309 | 0.040 |
Why?
|
Bone Plates | 1 | 2002 | 468 | 0.040 |
Why?
|
Culture Media, Conditioned | 1 | 2020 | 537 | 0.040 |
Why?
|
Microspheres | 1 | 2002 | 777 | 0.040 |
Why?
|
Bone Screws | 1 | 2002 | 520 | 0.040 |
Why?
|
Peritoneum | 1 | 1999 | 228 | 0.040 |
Why?
|
Postoperative Period | 2 | 2020 | 1842 | 0.040 |
Why?
|
Disease Models, Animal | 3 | 2009 | 18029 | 0.040 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 1998 | 75 | 0.040 |
Why?
|
Ovarian Cysts | 1 | 1999 | 115 | 0.040 |
Why?
|
Keratins | 1 | 1999 | 515 | 0.040 |
Why?
|
Ovary | 2 | 2012 | 981 | 0.040 |
Why?
|
Colloids | 1 | 1998 | 136 | 0.040 |
Why?
|
Water-Electrolyte Imbalance | 1 | 1999 | 113 | 0.040 |
Why?
|
Menotropins | 2 | 2012 | 45 | 0.040 |
Why?
|
Estrogens, Non-Steroidal | 1 | 1997 | 54 | 0.040 |
Why?
|
Diethylstilbestrol | 1 | 1997 | 93 | 0.040 |
Why?
|
Hydroxyproline | 1 | 2017 | 116 | 0.040 |
Why?
|
Urinary Catheterization | 1 | 2018 | 202 | 0.040 |
Why?
|
Biopsy | 2 | 2022 | 6756 | 0.040 |
Why?
|
Paracrine Communication | 1 | 1998 | 277 | 0.040 |
Why?
|
Embryo, Mammalian | 4 | 2000 | 1701 | 0.040 |
Why?
|
Embryonic and Fetal Development | 1 | 1997 | 438 | 0.040 |
Why?
|
Insurance Claim Review | 1 | 2001 | 720 | 0.040 |
Why?
|
Gonadotropins | 1 | 1997 | 241 | 0.040 |
Why?
|
Equipment Design | 2 | 1997 | 3582 | 0.040 |
Why?
|
Health Care Surveys | 2 | 2018 | 2453 | 0.040 |
Why?
|
Osteosarcoma | 1 | 2002 | 881 | 0.040 |
Why?
|
Abdominal Muscles | 1 | 1997 | 166 | 0.040 |
Why?
|
RNA Probes | 1 | 1996 | 113 | 0.030 |
Why?
|
Heymann Nephritis Antigenic Complex | 1 | 1995 | 16 | 0.030 |
Why?
|
bcl-2-Associated X Protein | 1 | 1997 | 295 | 0.030 |
Why?
|
Risk Assessment | 4 | 2021 | 23338 | 0.030 |
Why?
|
Norway | 1 | 2017 | 448 | 0.030 |
Why?
|
Hyponatremia | 1 | 1999 | 298 | 0.030 |
Why?
|
False Negative Reactions | 1 | 1997 | 588 | 0.030 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2022 | 1205 | 0.030 |
Why?
|
bcl-X Protein | 1 | 1997 | 411 | 0.030 |
Why?
|
Menstruation | 1 | 2017 | 302 | 0.030 |
Why?
|
Blotting, Northern | 1 | 1997 | 1581 | 0.030 |
Why?
|
Microinjections | 1 | 1996 | 327 | 0.030 |
Why?
|
Laminin | 1 | 2017 | 419 | 0.030 |
Why?
|
Rabbits | 3 | 1997 | 4894 | 0.030 |
Why?
|
Postoperative Hemorrhage | 1 | 1999 | 413 | 0.030 |
Why?
|
Immunoblotting | 1 | 1998 | 1682 | 0.030 |
Why?
|
Mice | 3 | 1999 | 81183 | 0.030 |
Why?
|
Europe | 1 | 2001 | 3339 | 0.030 |
Why?
|
Electrodes | 1 | 1997 | 619 | 0.030 |
Why?
|
Needles | 1 | 2017 | 449 | 0.030 |
Why?
|
Fatigue | 1 | 2002 | 1531 | 0.030 |
Why?
|
Safety | 1 | 1999 | 1186 | 0.030 |
Why?
|
Follistatin | 3 | 2000 | 141 | 0.030 |
Why?
|
Choice Behavior | 1 | 2020 | 803 | 0.030 |
Why?
|
Biosensing Techniques | 1 | 2020 | 668 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1375 | 0.030 |
Why?
|
Longitudinal Studies | 3 | 2015 | 13989 | 0.030 |
Why?
|
Animals | 12 | 2018 | 168757 | 0.030 |
Why?
|
United States | 3 | 2015 | 69872 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 35421 | 0.030 |
Why?
|
Polycystic Ovary Syndrome | 1 | 1997 | 370 | 0.030 |
Why?
|
Mucous Membrane | 1 | 2017 | 673 | 0.030 |
Why?
|
Chorionic Gonadotropin | 2 | 2012 | 477 | 0.030 |
Why?
|
Tissue Distribution | 1 | 1997 | 2327 | 0.030 |
Why?
|
Buserelin | 1 | 2012 | 17 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2022 | 39050 | 0.030 |
Why?
|
Reproductive Control Agents | 1 | 2012 | 7 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2020 | 19229 | 0.030 |
Why?
|
Macrophages, Peritoneal | 1 | 2014 | 251 | 0.030 |
Why?
|
Endometrial Neoplasms | 1 | 2002 | 1353 | 0.030 |
Why?
|
3-Hydroxysteroid Dehydrogenases | 1 | 1992 | 34 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2002 | 2418 | 0.030 |
Why?
|
Steroids | 1 | 1997 | 930 | 0.030 |
Why?
|
Consensus | 1 | 2021 | 2959 | 0.030 |
Why?
|
Insemination, Artificial | 1 | 2012 | 98 | 0.030 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2012 | 162 | 0.030 |
Why?
|
Genetic Markers | 1 | 2018 | 2634 | 0.030 |
Why?
|
Adnexal Diseases | 1 | 1993 | 102 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2019 | 1678 | 0.030 |
Why?
|
Hydrogels | 1 | 2017 | 724 | 0.030 |
Why?
|
Premenopause | 1 | 2015 | 1033 | 0.020 |
Why?
|
Cytoplasm | 1 | 1996 | 1539 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 1999 | 2382 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2017 | 1182 | 0.020 |
Why?
|
Heart Rate, Fetal | 1 | 1991 | 75 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2013 | 712 | 0.020 |
Why?
|
Dilatation | 1 | 1992 | 291 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20129 | 0.020 |
Why?
|
Laser Coagulation | 1 | 1993 | 326 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2013 | 479 | 0.020 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2012 | 401 | 0.020 |
Why?
|
Autoantigens | 1 | 1995 | 892 | 0.020 |
Why?
|
Densitometry | 1 | 1990 | 156 | 0.020 |
Why?
|
Glucans | 1 | 2010 | 72 | 0.020 |
Why?
|
Activin Receptors | 2 | 2000 | 43 | 0.020 |
Why?
|
Single-Blind Method | 2 | 2010 | 1590 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2002 | 2529 | 0.020 |
Why?
|
Ligands | 1 | 2017 | 3282 | 0.020 |
Why?
|
Surface Properties | 1 | 2012 | 1184 | 0.020 |
Why?
|
Oxidoreductases | 1 | 1992 | 424 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2015 | 57776 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2019 | 6622 | 0.020 |
Why?
|
Protein Precursors | 1 | 1994 | 1154 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1991 | 2186 | 0.020 |
Why?
|
Growth Hormone | 1 | 1992 | 705 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2013 | 578 | 0.020 |
Why?
|
Cost-Benefit Analysis | 3 | 2007 | 5391 | 0.020 |
Why?
|
Protease Inhibitors | 1 | 2012 | 791 | 0.020 |
Why?
|
Models, Biological | 2 | 2017 | 9583 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2012 | 1801 | 0.020 |
Why?
|
Hospitals | 1 | 2002 | 3952 | 0.020 |
Why?
|
Collagen | 1 | 2017 | 2689 | 0.020 |
Why?
|
Regeneration | 1 | 2017 | 1485 | 0.020 |
Why?
|
DNA Damage | 1 | 1998 | 2432 | 0.020 |
Why?
|
Particle Size | 1 | 2012 | 1642 | 0.020 |
Why?
|
Activins | 2 | 2000 | 208 | 0.020 |
Why?
|
Prednisone | 1 | 2012 | 1574 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2002 | 11031 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 1991 | 1799 | 0.020 |
Why?
|
Macrophages | 1 | 2002 | 5655 | 0.020 |
Why?
|
Spectrometry, Fluorescence | 1 | 1989 | 689 | 0.020 |
Why?
|
Antibodies | 1 | 1995 | 2460 | 0.020 |
Why?
|
Sus scrofa | 1 | 2008 | 437 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2013 | 1462 | 0.020 |
Why?
|
Logistic Models | 3 | 2013 | 13408 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2014 | 12072 | 0.020 |
Why?
|
Time Management | 1 | 2006 | 50 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2020 | 21746 | 0.020 |
Why?
|
Time Factors | 4 | 2007 | 40075 | 0.020 |
Why?
|
Ambulatory Care | 1 | 1997 | 2708 | 0.020 |
Why?
|
Embryo Implantation | 2 | 1998 | 272 | 0.020 |
Why?
|
Rats | 3 | 2009 | 24260 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 1997 | 4456 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2001 | 15076 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 1997 | 2408 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2009 | 1901 | 0.020 |
Why?
|
Epithelium | 1 | 1989 | 1679 | 0.020 |
Why?
|
Cell Line | 2 | 2013 | 15997 | 0.020 |
Why?
|
Stem Cells | 1 | 2017 | 3567 | 0.010 |
Why?
|
Trans-Activators | 1 | 2014 | 2924 | 0.010 |
Why?
|
Opioid-Related Disorders | 1 | 2018 | 2065 | 0.010 |
Why?
|
Ultrasonography, Prenatal | 1 | 1991 | 1695 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2012 | 2107 | 0.010 |
Why?
|
Office Visits | 1 | 2007 | 598 | 0.010 |
Why?
|
Electric Impedance | 1 | 2007 | 729 | 0.010 |
Why?
|
Telemedicine | 1 | 2020 | 2872 | 0.010 |
Why?
|
DNA | 1 | 2017 | 7301 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16689 | 0.010 |
Why?
|
Phenotype | 2 | 2018 | 16365 | 0.010 |
Why?
|
Software | 1 | 1997 | 4443 | 0.010 |
Why?
|
Sperm Immobilizing Agents | 1 | 2002 | 2 | 0.010 |
Why?
|
Zona Pellucida | 1 | 2002 | 18 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10388 | 0.010 |
Why?
|
Random Allocation | 1 | 2007 | 2429 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2012 | 6038 | 0.010 |
Why?
|
Molecular Weight | 2 | 1995 | 2255 | 0.010 |
Why?
|
Phospholipases A | 1 | 2002 | 216 | 0.010 |
Why?
|
Type C Phospholipases | 1 | 2002 | 292 | 0.010 |
Why?
|
Second Messenger Systems | 1 | 2002 | 206 | 0.010 |
Why?
|
Computational Biology | 1 | 2013 | 3521 | 0.010 |
Why?
|
Binding Sites | 1 | 1989 | 6114 | 0.010 |
Why?
|
Genome, Human | 1 | 2014 | 4420 | 0.010 |
Why?
|
New England | 1 | 2003 | 1022 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2006 | 1681 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12245 | 0.010 |
Why?
|
Proteomics | 1 | 2013 | 3638 | 0.010 |
Why?
|
Signal Transduction | 1 | 2002 | 23403 | 0.010 |
Why?
|
Receptors, LHRH | 1 | 1999 | 160 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2003 | 2557 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1995 | 9274 | 0.010 |
Why?
|
Anxiety | 1 | 2012 | 4297 | 0.010 |
Why?
|
GTP-Binding Proteins | 1 | 2002 | 970 | 0.010 |
Why?
|
Glucose | 1 | 2010 | 4397 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 1989 | 4560 | 0.010 |
Why?
|
Male | 7 | 2003 | 350118 | 0.010 |
Why?
|
Swine | 1 | 2007 | 5917 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17446 | 0.010 |
Why?
|
Liver | 1 | 1992 | 7474 | 0.010 |
Why?
|
Probability | 1 | 2002 | 2505 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 25043 | 0.010 |
Why?
|
Progesterone | 1 | 2000 | 776 | 0.010 |
Why?
|
Age Distribution | 1 | 2002 | 2902 | 0.010 |
Why?
|
Proteins | 1 | 1990 | 6103 | 0.010 |
Why?
|
Immune Sera | 1 | 1994 | 641 | 0.010 |
Why?
|
Cryopreservation | 1 | 1998 | 670 | 0.010 |
Why?
|
Follicular Phase | 1 | 1994 | 153 | 0.010 |
Why?
|
Neodymium | 1 | 1993 | 21 | 0.010 |
Why?
|
Erbium | 1 | 1993 | 12 | 0.010 |
Why?
|
Holmium | 1 | 1993 | 30 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1994 | 919 | 0.010 |
Why?
|
Aluminum Silicates | 1 | 1993 | 26 | 0.010 |
Why?
|
Yttrium | 1 | 1993 | 35 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2007 | 3507 | 0.010 |
Why?
|
Depression | 1 | 2012 | 7766 | 0.010 |
Why?
|
3-alpha-Hydroxysteroid Dehydrogenase (B-Specific) | 1 | 1992 | 7 | 0.010 |
Why?
|
Actins | 1 | 2000 | 2121 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2002 | 2866 | 0.010 |
Why?
|
Data Collection | 1 | 2002 | 3341 | 0.010 |
Why?
|
Hypophysectomy | 1 | 1992 | 113 | 0.010 |
Why?
|
Cross Reactions | 1 | 1994 | 841 | 0.010 |
Why?
|
Enzyme Induction | 1 | 1992 | 475 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2004 | 3589 | 0.010 |
Why?
|
Recovery of Function | 1 | 2002 | 2925 | 0.010 |
Why?
|
Pulse | 1 | 1991 | 229 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 3798 | 0.010 |
Why?
|
Laparotomy | 1 | 1993 | 473 | 0.010 |
Why?
|
Immunization | 1 | 1995 | 1256 | 0.010 |
Why?
|
Age Factors | 2 | 2001 | 18370 | 0.010 |
Why?
|
Fetal Heart | 1 | 1991 | 276 | 0.010 |
Why?
|
Neoplasms | 1 | 1998 | 21683 | 0.010 |
Why?
|
Regression Analysis | 1 | 1999 | 6459 | 0.010 |
Why?
|
Cytosol | 1 | 1992 | 901 | 0.010 |
Why?
|
Genital Neoplasms, Female | 1 | 1994 | 523 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 1993 | 1150 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2007 | 7659 | 0.000 |
Why?
|
Hospitalization | 1 | 2007 | 10262 | 0.000 |
Why?
|
Amino Acids | 1 | 1994 | 1736 | 0.000 |
Why?
|
Photochemotherapy | 1 | 1994 | 807 | 0.000 |
Why?
|
Epitopes | 1 | 1994 | 2571 | 0.000 |
Why?
|
Autoimmunity | 1 | 1995 | 1349 | 0.000 |
Why?
|
Colonic Neoplasms | 1 | 1998 | 2541 | 0.000 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1998 | 2020 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2002 | 15540 | 0.000 |
Why?
|
Reoperation | 1 | 1993 | 4201 | 0.000 |
Why?
|
Gestational Age | 1 | 1991 | 3493 | 0.000 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1998 | 4034 | 0.000 |
Why?
|
Burns | 1 | 1993 | 1815 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 1998 | 6364 | 0.000 |
Why?
|
Echocardiography | 1 | 1991 | 5102 | 0.000 |
Why?
|
Sex Factors | 1 | 1992 | 10397 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1998 | 13102 | 0.000 |
Why?
|